Cardiovascular Revascularization Medicine
Volume 10, Issue 1 , Pages 45-48, January 2009

Computerized gradual balloon inflation: a novel strategy of coronary angioplasty superior to a standard manual approach

Department of Cardiology, Hadassah-Hebrew University Medical Center, Ein Kerem and Mount Scopus, Jerusalem, Israel

Received 19 March 2008; received in revised form 27 May 2008; accepted 12 June 2008.

Abstract 

Background

Mechanical trauma caused by PCI is a primary reason for restenosis and subsequent target lesion revascularization (TLR). To minimize this trauma, we developed a computerized angioplasty pressure sensor and inflator device (CAPSID) for gradual inflation. The objective of this prospective randomized study was to examine whether use of CAPSID reduces early and late cardiac events in patients undergoing PCI.

Methods

Patients undergoing PCI were eligible and randomized to CAPSID or standard balloon inflation (plain old balloon angioplasty). In the CAPSID group, a slow, gradual balloon inflation was performed by a personal computer. Stenting was used in both groups only for suboptimal results. Patients with total occlusions and vein grafts were excluded. Clinical follow-up for major adverse cardiac events (MACE) was performed at 6 and 12 months, with repeat coronary angiography performed for clinical symptoms or positive stress testing.

Results

A total of 234 patients completed the study. At 1-year follow-up, the CAPSID group had a significantly lower rate of MACE (21% vs. 37%, P<.005). In patients who underwent angiography, there was a significantly lower rate of restenosis in the CAPSID group (20.2% vs. 35.5%). The reduction in TLR was even more pronounced in the subgroup undergoing stenting (8% vs. 24%; P<.001).

Conclusions

We conclude that gradual computerized balloon inflation is more effective than standard manual balloon inflation in reducing adverse coronary events. The combination of CAPSID and subsequent stent deployment was especially effective in reducing TLR.

Keywords: Balloon angioplasty, Stenting, Coronary artery disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 There was no financial support for the study. Iony Katz and A. Teddy Weiss are patent holders for the CAPSID system.

PII: S1553-8389(08)00240-6

doi:10.1016/j.carrev.2008.06.002

Cardiovascular Revascularization Medicine
Volume 10, Issue 1 , Pages 45-48, January 2009